WallStreetZenWallStreetZen

NASDAQ: NTLA
Intellia Therapeutics Inc Stock Ownership - Who owns Intellia Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Intellia Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Muna BhanjiDirector2025-04-29265$8.50
$2.25kSell
Eliana ClarkEVP Chief Technical Officer2025-03-04679$8.99
$6.10kSell
James BastaEVP General Counsel2025-03-042,572$8.99
$23.12kSell
Muna BhanjiDirector2025-01-29265$9.97
$2.64kSell
James BastaEVP General Counsel2025-01-037,074$12.18
$86.16kSell
Derek HicksEVP Chief Business Officer2025-01-036,502$12.18
$79.19kSell
David LebwohlEVP Chief Medical Officer2025-01-039,557$12.18
$116.40kSell
John M. LeonardPresident and CEO2025-01-0326,807$12.18
$326.51kSell
Laura SepplorenzinoEVP Chief Scientific Officer2025-01-038,966$12.18
$109.21kSell
Eliana ClarkEVP Chief Technical Officer2025-01-037,422$12.18
$90.40kSell

1 of 2

NTLA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NTLA insiders and whales buy or sell their stock.

NTLA Shareholders

What type of owners hold Intellia Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC12.56%13,011,015$108.12MInstitution
Vanguard Group Inc10.38%10,752,031$89.35MInstitution
Blackrock Inc10.19%10,556,190$87.72MInstitution
Rachel E. Haurwitz5.40%5,593,846$46.48MInsider
Caribou Therapeutics Holdco LLC5.40%5,593,846$46.48MInsider
State Street Corp4.35%4,510,261$37.48MInstitution
Novartis Institutes For Biomedical Research Inc4.20%4,352,295$36.17MInsider
Caribou Biosciences Inc3.86%3,994,355$33.19MInsider
Morgan Stanley3.67%3,801,695$31.59MInstitution
Capital International Investors3.65%3,779,424$31.41MInstitution

1 of 3

NTLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NTLA72.20%27.80%Net SellingNet Selling
ARDX42.09%57.91%Net BuyingNet Buying
QURE87.80%12.20%Net Selling
SNDX91.93%8.07%Net BuyingNet Buying
ZYME53.50%46.50%Net BuyingNet Buying
View Top Biotech Stocks

Intellia Therapeutics Stock Ownership FAQ

Who owns Intellia Therapeutics?

Intellia Therapeutics (NASDAQ: NTLA) is owned by 97.73% institutional shareholders, 37.62% Intellia Therapeutics insiders, and 0.00% retail investors. Rachel E. Haurwitz is the largest individual Intellia Therapeutics shareholder, owning 5.59M shares representing 5.40% of the company. Rachel E. Haurwitz's Intellia Therapeutics shares are currently valued at $46.48M.

If you're new to stock investing, here's how to buy Intellia Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.